Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
Summary
The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
Official title: A Multi-center, Single-arm, Real-world Registry Assessing the Clinical Use of the Lifetech CeraFlex™ ASD Closure System
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
145
Start Date
2024-07-09
Completion Date
2027-12
Last Updated
2025-01-08
Healthy Volunteers
No
Conditions
Interventions
CeraFlex™ Atrial Septal Defect (ASD) Closure System
The CeraFlex™ ASD Occluder have two types of occluders, CeraFlex™ ASD Occluder and CeraFlex™ Multi-fenestrated (Cribriform) ASD Occluder. The CeraFlex™ ASD Occluder is percutaneous, transcatheter closure devices for the non-surgical closure of atrial septal defects.
Locations (7)
Hospital Pequeno Príncipe
Curitiba, Brazil
Universidade Federal do Ceará
Fortaleza, Brazil
Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Brazil
HCOR - Associação Beneficente Síria
São Paulo, Brazil
Hospital Beneficência Portuguesa
São Paulo, Brazil
Onassis Cardiac Surgery Center
Kallithea, Greece
IRCCS Policlinico San Donato
Milan, Italy